Suraksha Diagnostic [SURAKSHA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Suraksha Diagnostic

NSE
Loading...

Qualitek Labs

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Suraksha Diagnostic wins in 8 metrics, Qualitek Labs wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricSuraksha DiagnosticQualitek LabsBetter
P/E Ratio (TTM)46.6358.45Suraksha Diagnostic
Price-to-Book Ratio7.334.77Qualitek Labs
Debt-to-Equity Ratio42.2837.74Qualitek Labs
PEG Ratio2.58N/AN/A
EV/EBITDA23.7126.39Suraksha Diagnostic
Profit Margin (TTM)12.62%8.97%Suraksha Diagnostic
Operating Margin (TTM)19.43%20.77%Qualitek Labs
EBITDA Margin (TTM)19.43%20.77%Qualitek Labs
Return on Equity15.14%12.27%Suraksha Diagnostic
Return on Assets (TTM)9.54%7.21%Suraksha Diagnostic
Free Cash Flow (TTM)$213.35M$-128.53MSuraksha Diagnostic
1-Year Return-28.29%17.73%Qualitek Labs
Price-to-Sales Ratio (TTM)5.876.89Suraksha Diagnostic
Enterprise Value$16.17B$4.30BSuraksha Diagnostic
EV/Revenue Ratio6.136.12Qualitek Labs
Gross Profit Margin (TTM)87.94%N/AN/A
Revenue per Share (TTM)$51$79Qualitek Labs
Earnings per Share (Diluted)$6.38$7.10Qualitek Labs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Suraksha Diagnostic vs Qualitek Labs Stock Performance Analysis

Loading Price Chart...

Suraksha Diagnostic
Qualitek Labs
Suraksha Diagnostic Stock Overview | Qualitek Labs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Suraksha Diagnostic0.57%0.40%-1.30%-7.10%4.82%-21.28%
Qualitek Labs-1.19%3.75%9.21%36.07%59.00%13.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Suraksha Diagnostic-28.29%-28.29%-28.29%-28.29%-28.29%-28.29%
Qualitek Labs17.73%168.09%168.09%168.09%168.09%168.09%

News Based Sentiment: Suraksha Diagnostic vs Qualitek Labs

Suraksha Diagnostic

News based Sentiment: MIXED

September presented a mixed bag for Suraksha Diagnostic. While the company demonstrated strong financial performance and strategic expansion with the launch of 'Suraksha Genomics,' these positives were offset by a declining share price, mixed analyst opinions, and decreasing investor interest. This creates a cautiously optimistic outlook for investors.

View Suraksha Diagnostic News Sentiment Analysis

Qualitek Labs

News based Sentiment: MIXED

September was a strong month for Qualitek Labs with significant contract wins and an acquisition, driving stock gains. However, the resignation of a key personnel and concerning trading volume patterns introduce some uncertainty, creating a mixed investment narrative. The preferential allotment of shares solidifies a previous agreement, adding stability.

View Qualitek Labs News Sentiment Analysis

Performance & Financial Health Analysis: Suraksha Diagnostic vs Qualitek Labs

MetricSURAKSHAQLL
Market Information
Market Cap i₹16.14B₹4.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i65,0489,840
90 Day Avg. Volume i49,52311,293
Last Close₹299.20₹415.00
52 Week Range₹231.00 - ₹449.00₹215.05 - ₹458.95
% from 52W High-33.36%-9.58%
All-Time High₹449.00 (Dec 02, 2024)₹458.95 (Sep 19, 2025)
% from All-Time High-33.36%-9.58%
Growth Metrics
Quarterly Revenue Growth0.21%N/A
Quarterly Earnings Growth0.18%N/A
Financial Health
Profit Margin (TTM) i0.13%0.09%
Operating Margin (TTM) i0.19%0.21%
Return on Equity (TTM) i0.15%0.12%
Debt to Equity (MRQ) i42.2837.74
Cash & Liquidity
Book Value per Share (MRQ)₹40.56₹86.99
Cash per Share (MRQ)₹3.86₹1.78
Operating Cash Flow (TTM) i₹365.13M₹104.99M
Levered Free Cash Flow (TTM) i₹318.24M₹-329,006,240
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Suraksha Diagnostic vs Qualitek Labs

MetricSURAKSHAQLL
Price Ratios
P/E Ratio (TTM) i46.6358.45
Forward P/E i31.82N/A
PEG Ratio i2.58N/A
Price to Sales (TTM) i5.876.89
Price to Book (MRQ) i7.334.77
Market Capitalization
Market Capitalization i₹16.14B₹4.84B
Enterprise Value i₹16.17B₹4.30B
Enterprise Value Metrics
Enterprise to Revenue i6.136.12
Enterprise to EBITDA i23.7126.39
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i₹40.56₹86.99

Financial Statements Comparison: Suraksha Diagnostic vs Qualitek Labs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SURAKSHAQLL
Revenue/Sales i₹725.86MN/A
Cost of Goods Sold i₹87.51MN/A
Gross Profit i₹638.36MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i₹133.78MN/A
EBITDA i₹237.66MN/A
Pre-Tax Income i₹124.69MN/A
Income Tax i₹32.94MN/A
Net Income (Profit) i₹91.75MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SURAKSHAQLL
Cash & Equivalents i₹22.47M₹43.10M
Total Current Assets i₹471.53M₹426.08M
Total Current Liabilities i₹427.17M₹325.84M
Long-Term Debt i₹741.03M₹308.61M
Total Shareholders Equity i₹2.10B₹927.82M
Retained Earnings i₹1.54B₹145.04M
Property, Plant & Equipment i₹1.38B₹589.98M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SURAKSHAQLL
Operating Cash Flow i₹148.52MN/A
Capital Expenditures i₹-123.19MN/A
Free Cash Flow i₹64.63MN/A
Debt Repayment i₹-7.29MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSURAKSHAQLL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i65,0489,840
Average Daily Volume (90 Day) i49,52311,293
Shares Outstanding i52.08M9.98M
Float Shares i21.51M4.17M
% Held by Insiders i0.62%0.59%
% Held by Institutions i0.23%0.00%

Dividend Analysis & Yield Comparison: Suraksha Diagnostic vs Qualitek Labs

MetricSURAKSHAQLL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A